Oxytocin releases atrial natriuretic peptide by combining with oxytocin receptors in the heart.
Previous studies indicated that the central nervous system induces release of the cardiac hormone atrial natriuretic peptide (ANP) by release of oxytocin from the neurohypophysis. The presence of specific transcripts for the oxytocin receptor was demonstrated in all chambers of the heart by amplification of cDNA by the PCR using specific oligonucleotide primers. Oxytocin receptor mRNA content in the heart is 10 times lower than in the uterus of female rats. Oxytocin receptor transcripts were demonstrated by in situ hybridization in atrial and ventricular sections and confirmed by competitive binding assay using frozen heart sections. Perfusion of female rat hearts for 25 min with Krebs-Henseleit buffer resulted in nearly constant release of ANP. Addition of oxytocin (10(-6) M) significantly stimulated ANP release, and an oxytocin receptor antagonist (10(-7) and 10(-6) M) caused dose-related inhibition of oxytocin-induced ANP release and in the last few minutes of perfusion decreased ANP release below that in control hearts, suggesting that intracardiac oxytocin stimulates ANP release. In contrast, brain natriuretic peptide release was unaltered by oxytocin. During perfusion, heart rate decreased gradually and it was further decreased significantly by oxytocin (10(-6) M). This decrease was totally reversed by the oxytocin antagonist (10(-6) M) indicating that oxytocin released ANP that directly slowed the heart, probably by release of cyclic GMP. The results indicate that oxytocin receptors mediate the action of oxytocin to release ANP, which slows the heart and reduces its force of contraction to produce a rapid reduction in circulating blood volume.
Gutkowska
J
J
Centre de recherche, Centre Hospitalier de l'Université de Montréal, Pavillon Hôtel-Dieu, 3840 rue Saint-Urbain, Montreal, PQ, Canada H2W 1T8. gutkowsj@ere.umontreal.ca
Jankowski
M
M
Lambert
C
C
Mukaddam-Daher
S
S
Zingg
H H
HH
McCann
S M
SM
D000818:Animals; D001011:Aorta / Q000378:metabolism; D009320:Atrial Natriuretic Factor / Q000378:metabolism*; D017931:DNA Primers; D005260:Female; D006321:Heart / Q000187:drug effects*; D017403:In Situ Hybridization; D008955:Models, Cardiovascular; D009206:Myocardium / Q000378:metabolism; D020097:Natriuretic Peptide, Brain; D009419:Nerve Tissue Proteins / Q000378:metabolism; D010121:Oxytocin / Q000096:biosynthesis / Q000378:metabolism* / Q000494:pharmacology*; D016133:Polymerase Chain Reaction; D012333:RNA, Messenger / Q000096:biosynthesis; D051381:Rats; D017207:Rats, Sprague-Dawley; D018045:Receptors, Oxytocin / Q000096:biosynthesis / Q000187:drug effects / Q000502:physiology*; D014158:Transcription, Genetic; D014599:Uterus / Q000378:metabolism
D017931:DNA Primers; D009419:Nerve Tissue Proteins; D012333:RNA, Messenger; D018045:Receptors, Oxytocin; D020097:Natriuretic Peptide, Brain; D010121:Oxytocin; D009320:Atrial Natriuretic Factor